MOSCOW, February 15 – RIA Novosti. The Russian Sputnik V vaccine may be approved by the Indian regulator within the next few weeks, after which it can be produced in that country, Indian Ambassador to Moscow Venkatesh Varma told RIA Novosti.
“The Russian Sputnik V vaccine is being tested in India and is expected to be approved by the Indian regulator over the next few weeks,” the ambassador said.
After that, he said, “the Russian vaccine will be produced in India for India, for Russia and for the markets of third countries.” “This will be the most important contribution of our countries to the fight against the pandemic,” he said.
Varma also said that the topic of Russian-Indian vaccine production will be on the agenda of talks of the Indian Deputy Foreign Minister in Moscow on February 17-18.
“India and Russia are very important countries in the production of anti-coronavirus vaccines. India has one of the largest production facilities in the world,” the Indian ambassador emphasized.
At the moment, only two vaccines against coronavirus are allowed in India – the Indian version of the “Oxford” vaccine called Covieshield and the domestic Covaxin. At the same time, as First Deputy Minister of Health Rajesh Bhushan said earlier, the country's authorities may soon consider the use of four more vaccines, including Russia's Sputnik V.
India is in the second place in the world in the number of detected cases of coronavirus. According to the latest data from the Ministry of Health, a total of 10.9 million cases of COVID-19 have been registered in the country. At the same time, more than 10.6 million people have defeated the disease, about 139 thousand are continuing treatment, 155 thousand people have died from coronavirus and concomitant diseases.
According to the latest data from the Indian Ministry of Health, 8.25 million people have been vaccinated in the country, including 5.98 million doctors and 2.27 million of those who help them in the fight against coronavirus – police and emergency services. At the same time, 24.5 thousand people have already received the second dose of the vaccine.